EP

Epi Biotech Co., Ltd.

Developing alopecia therapies, skin regeneration products, and preclinical CRO services.

446440 | KO

Overview

Corporate Details

ISIN(s):
KR7446440000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 엠동 1903호(송도동, 송도테크노파크아이티센터), 인천광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Epi Biotech Co., Ltd. is an advanced biopharmaceutical company specializing in the research and development of treatments for alopecia (hair loss). The company focuses on developing a pipeline of innovative cell and antibody therapies to meet the demand for hair restoration. It also provides preclinical Contract Research Organization (CRO) services for hair loss studies. Additionally, Epi Biotech conducts R&D in skin regeneration treatments with the goal of creating commercially viable consumer products. The company leverages what it describes as South Korea's largest alopecia genomic database to support its research efforts.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-31 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 8.2 KB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 20.6 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 12.9 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 71.6 KB
2025-06-24 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.1 KB
2025-06-24 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-05-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 168.9 KB
2025-04-24 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB
2025-04-16 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 51.4 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.2 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 91.4 KB
2025-03-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB
2025-03-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제3자배정 유상증자)
Korean 5.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 9.8 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 748.3 KB

Automate Your Workflow. Get a real-time feed of all Epi Biotech Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Epi Biotech Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Epi Biotech Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Develops advanced therapies for rare lysosomal storage disorders.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America
ANTX
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom
ANAN
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
United States of America
ANAB
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye
ANGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.